Human Stem Cells Institute (ISKJ):企業の財務・戦略的SWOT分析

◆英語タイトル:Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH194414FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Human Stem Cells Institute (HSCI) is a biotech company that provides discovery, research and development, and marketing of proprietary products and services in the areas of regenerative medicine, medical genetics, bio-insurance, gene therapy and biopharmaceutics. The company offers neovasculgen, a gene-therapy drug for treatment of peripheral arterial disease including critical limb ischemia; and SPRS-therapy, a set of personalized diagnostics and treatment procedures for repairing skin damage. Its neovasculgen is a gene-therapy drug, which is used in the treatment of peripheral arterial disease. HSCI also provides gemacell, a cell-based drug candidate for the treatment of myocardial infarction; and prenetix, a non-invasive prenatal diagnosis of fetal chromosome abnormalities. It owns and operates a reproductive cell and tissue bank for personal storage and donation. HSCI is headquartered in Moscow, Russia.

This comprehensive SWOT profile of Human Stem Cells Institute provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Human Stem Cells Institute including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Human Stem Cells Institute – Key Information
Human Stem Cells Institute – Overview
Human Stem Cells Institute – Key Employees
Human Stem Cells Institute – Key Employee Biographies
Human Stem Cells Institute – Key Operational Heads
Human Stem Cells Institute – Major Products and Services
Human Stem Cells Institute – History
Human Stem Cells Institute – Company Statement
Human Stem Cells Institute – Locations And Subsidiaries
Human Stem Cells Institute
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Human Stem Cells Institute – Business Description
Human Stem Cells Institute – Corporate Strategy
Human Stem Cells Institute – SWOT Analysis
SWOT Analysis – Overview
Human Stem Cells Institute – Strengths
Human Stem Cells Institute – Weaknesses
Human Stem Cells Institute – Opportunities
Human Stem Cells Institute – Threats
Human Stem Cells Institute – Key Competitors

Section 3 – Company Financial Performance Charts

Human Stem Cells Institute – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Human Stem Cells Institute, Key Information
Human Stem Cells Institute, Key Ratios
Human Stem Cells Institute, Share Data
Human Stem Cells Institute, Major Products and Services
Human Stem Cells Institute, History
Human Stem Cells Institute, Key Employees
Human Stem Cells Institute, Key Employee Biographies
Human Stem Cells Institute, Key Operational Heads
Human Stem Cells Institute, Other Locations
Human Stem Cells Institute, Subsidiaries
Human Stem Cells Institute, Key Competitors
Human Stem Cells Institute, SWOT Analysis
Human Stem Cells Institute, Ratios based on current share price
Human Stem Cells Institute, Annual Ratios
Human Stem Cells Institute, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Human Stem Cells Institute (ISKJ):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Hynix Inc (000660):企業の財務・戦略的SWOT分析
    SK Hynix Inc (000660) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nestle (Malaysia) Bhd:企業の戦略・SWOT・財務情報
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BC Technical Inc-医療機器分野:企業M&A・提携分析
    Summary BC Technical Inc (BC Technical), a subsidiary of MSouth Equity Partners is a medical device company that provides molecular imaging solutions. The company offers spare parts for new and refurbished nuclear medicine equipments for gamma cameras and BC backup server. It provides PET, PET/CT, N …
  • Ethypharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ethypharm SA (Ethypharm), a subsidiary of Astorg Partners is a pharmaceutical company that develops and manufactures drugs for the treatment of pain, gastrointestinal, cancer, cardiovascular and central nervous system diseases. The company provides products such as ibuprofen, paracetamol, pr …
  • SURFnet bv:企業の戦略的SWOT分析
    SURFnet bv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Stratasys Ltd.:戦略・SWOT・企業財務分析
    Stratasys Ltd. - Strategy, SWOT and Corporate Finance Report Summary Stratasys Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • Cognoptix Inc-医療機器分野:企業M&A・提携分析
    Summary Cognoptix Inc (Cognoptix), formerly Neuroptix Corp, is a medical device company that develops and offers eye-scanning test for the early detection and diagnosis of Alzheimer’s disease. The company develops technology which is used to detect the presence of Alzheimer’s related beta amyloid pr …
  • BioLamina AB:製薬・医療:M&Aディール及び事業提携情報
    Summary BioLamina AB (BioLamina) is a biotechnology company that focuses on the development, manufacture and distribution of cell culture reagents intended for culturing primary cells. The company offers a wide portfolio of chemically defined and xeno-free laminin proteins. Its product portfolio inc …
  • Lumos Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lumos Pharma Inc (Lumos Pharma) is a developer of novel therapies for the treatment of rare and neglected diseases. The company’s pipeline product includes LUM-001, LUM-201 and LUM-301. Its lead compound LUM001, is a small and planar molecule used for the treatment of rare disease, creatine …
  • Enmax Corporation-エネルギー分野:企業M&A・提携分析
    Summary ENMAX Corporation (ENMAX), a subsidiary of City of Calgary, is a vertically integrated energy company that generates, transmits and distributes electricity; supplies natural gas; and provides value-added services. Through its subsidiaries, the company undertakes deregulated electricity gener …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Merz Pharma GmbH & Co. KGaA:企業のM&A・事業提携・投資動向
    Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merz Pharma GmbH & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Xenetic Biosciences Inc (XBIO)-製薬・医療分野:企業M&A・提携分析
    Summary Xenetic Biosciences Inc (Xenetic), formerly General Sales & Leasing, Inc., is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of biologic drugs and innovative orphan cancer drugs. The company’s pipeline products include ErepoXen, Virexxa and OncoHis …
  • Northeastern Rural Electric Membership Corp:企業の戦略的SWOT分析
    Northeastern Rural Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • JD Sports Fashion Plc:企業の戦略・SWOT・財務情報
    JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report Summary JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • IMCO Industries Ltd.:企業の戦略・SWOT・財務情報
    IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Netcare Ltd (NTC):企業の財務・戦略的SWOT分析
    Summary Netcare Ltd (Netcare) is a healthcare service provider that offers patient care services. The center provides medical facilities and treatments in the fields of breast care, oncology, orthopedics, renal care, transplants and weight management. Its facilities include medicross centers, netcar …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務情報
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Epcor Utilities Inc:発電所・企業SWOT分析
    Epcor Utilities Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆